AAD: Sanofi showcases data on possible Dupixent successor Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic ...

Weekly Wednesday statement of assets and liabilities as required by the Bank of Canada Act. The figures for the last reference period are preliminary and are subject to revision.

JPMorgan Chase & Co. annual balance sheet for JPM company financials.

Nike Inc. Cl B annual balance sheet for NKE company financials.